IIP closes $105M initial investment in life science REIT IQHQ; first non-cannabis investment

INNOVATIVE INDUSTRIAL PROPERTIES INC

Initial investment of $105M: $100M in revolving credit facility and $5M in preferred stock (15% Series G-1) with warrants for 1.5% of common equity.
Remaining IQHQ preferred stock commitments total up to $165M, expected to fund in tranches from Q4 2025 to Q2 2027.
Drew $50M from existing $87.5M revolver; received commitment for new $100M secured revolver at SOFR+200bps (6.1% as of 9/30/25).
Transaction is IIP's first investment outside cannabis, providing portfolio diversification into life science.
Executive Chairman Alan Gold says transaction expected to generate significant earnings accretion for shareholders.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INNOVATIVE INDUSTRIAL PROPERTIES INC incurred revolving credit of $50.0 million with a federally regulated commercial bank at a variable rate based on the greater of (i) the prime rate plus an applicable ma maturing October 23, 2026.

Instrument: revolving credit
Principal: $50.0 million
Counterparty: a federally regulated commercial bank
Rate: a variable rate based on the greater of (i) the prime rate plus an applicable ma
Maturity: October 23, 2026
Event: incurrence

Exact text from the filing

the Company, through its operating partnership, IIP OP, drew $50.0 million under its previously disclosed $87.5 million existing revolving credit facility established pursuant a Loan Agreement, dated October 23, 2023, as amended

View on SEC.gov

306 debt financings filed in the last 30 days. Browse all debt financings →

INNOVATIVE INDUSTRIAL PROPERTIES INC filing history →

Source: SEC EDGAR

accession 0001104659-25-096061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.